Overactive Bladder - Results from #2220

EAU 2012 - The β3-adrenoceptor agonist Solabegron is safe and effective for improving symptoms of overactive bladder - Poster March 30, 2012

EAU 2012 - Urethral versus suprapubic catheter for patients with spinal cord injury induced neurogenic bladder: A study applying the eleven-year comprehensive nationwide database of Taiwan - Session Highlights March 30, 2012

EAU 2012 - Urodynamics practice workshop - Session Highlights March 30, 2012

EAU 2012 - Injecting DIGNITY into your neurogenic detrusor overactivity (NDO) patient treatment paradigm: The role of botulinum toxin type A - Session Highlights March 30, 2012

Etiology of overactive bladder: A diet and lifestyle model for diabetes and obesity in older women - Abstract March 28, 2012

An overview of treatment of overactive bladder syndrome in women - Abstract March 19, 2012

Impact of overactive bladder treatment on associated comorbidities - Abstract March 16, 2012

Standard pharmacological treatment and new therapies for overactive bladder - Abstract March 14, 2012

Contemporary management of overactive bladder - Abstract March 9, 2012

Pathophysiology of overactive bladder - Abstract March 7, 2012

Solifenacin for overactive bladder: A systematic review and meta-analysis - Abstract March 6, 2012

How does the urothelium affect bladder function in health and disease? - Abstract February 24, 2012

Physiopathology of overactive bladder syndrome - Abstract February 21, 2012

Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: Pooled analysis of two open-label extension studies - Abstract February 7, 2012

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients - Abstract February 7, 2012

Defining urinary urgency: Patient descriptions of "gotta go" - Abstract February 6, 2012

The effect of rectal distension on bladder function in patients with overactive bladder - Abstract February 3, 2012

The prevalence and therapeutic effect of constipation in pediatric overactive bladder - Abstract January 31, 2012

Which anticholinergic drug for overactive bladder symptoms in adults - Abstract January 30, 2012

Spanish cultural adaptation and psychometrical validation of the Treatment Benefit Scale (TBS) in the symptomatic treatment of overactive bladder - Abstract January 27, 2012

Page 112 of 121